Prof. Ronald Melki is co-organizer of Protein phase transitions in aging and age-related diseases conference

2022-05-03T15:35:47+01:00May 3rd, 2022|News, Partner in the Spotlight|

PD-MitoQUANT PI Prof. Dr Ronald Melki, CNRS, Fontenay-aux-Roses, France is the co-organizer of the Protein phase transitions in aging and age-related diseases: from atomic resolution to cellular solutions conference which will take place in Roscoff, Brittany, France from October 17th through the 21st, 2022. The deadline for applications is June 13th; click here for application guidelines. Invited speakers include PI Dr Olga Corti, ICM, who will speak about Mitochondrial quality control in Parkinson's disease and Ronald Melki, CNRS: Fibril polymorphisms and propagation About [...]

PD-MitoQUANT research presented by Mr Chenna, RCSI at IEEE BIBM 2021 meeting

2022-06-13T14:36:15+01:00December 2nd, 2021|News|

Sandeep Chenna The IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021 provides a leading forum for disseminating the latest research in bioinformatics and health informatics. It brings together academic and industrial scientists from computer science, biology, chemistry, medicine, mathematics and statistics. We solicit high-quality original research papers (including significant work-in-progress) in any aspect of bioinformatics, genomics, and biomedicine. Mr Sandeep Chenna of the Royal College of Surgeons in Ireland will present a short paper entitled 'Phenomenological equations for [...]

Save the Date: Parkinson’s UK Excellence Network Conference, November 4th

2021-05-31T09:41:47+01:00May 31st, 2021|News, Partner in the Spotlight|

Our partners at Parkinson's UK are organizing a 2021 Excellence Network Conference on November 4th, 2021. The online, one-day conference theme is 'Progression beyond the pandemic: what have we learned from coronavirus (COVID-19)?'. Together delegates will learn, share and discuss. The programme will focus on the future and share learning and experiences across the themes of: Restarting life after the pandemic Restarting services after the pandemic Technology Research Exercise The 8:00 AM-6:00 PM conference will assemble health and social care professionals, [...]

PROJECT FACTS

 

  • Grant agreement number 821522
  • IMI2 JU contribution €4,617,933.75
  • Duration 36 months
  • Starting date 1 February 2019

 

FUNDING ACKNOWLEDGEMENT

 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

Go to Top